Biomarker for atopic dermatitis and application thereof

The invention discloses a biomarker for atopic dermatitis and application of the biomarker. The inventor of the invention adopts liquid chromatography-mass spectrometry and data independent acquisition technology detection to find that the expression of aminolevulinic acid dehydratase (ALAD) in the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIU JUNFENG, ZHANG KAI, MO XIUMEI, YE SIQI, YAN FENGGEN, YU XIAOBO, CHEN DACAN, WANG SAIYA
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LIU JUNFENG
ZHANG KAI
MO XIUMEI
YE SIQI
YAN FENGGEN
YU XIAOBO
CHEN DACAN
WANG SAIYA
description The invention discloses a biomarker for atopic dermatitis and application of the biomarker. The inventor of the invention adopts liquid chromatography-mass spectrometry and data independent acquisition technology detection to find that the expression of aminolevulinic acid dehydratase (ALAD) in the blood of an atopic dermatitis patient is obviously reduced, and the ALAD can be well used as a marker for atopic dermatitis diagnosis and reaction severity, can provide objective laboratory indexes for disease diagnosis, and has a good application prospect. Precise treatment can be realized, and the method has important significance for improving the clinical curative effect. 本发明公开了特应性皮炎的生物标志物及其应用。本发明的发明人采用液质联用、数据非依赖性采集技术检测,发现特应性皮炎患者血液中氨基乙酰丙酸脱水酶(ALAD)表达明显下降,其能够很好作为特应性皮炎诊断和反应严重程度的标志物,可以为疾病的诊断提供客观的实验室指标,有助于实现精准治疗,对于提高临床疗效有重要意义。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116875675A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116875675A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116875675A3</originalsourceid><addsrcrecordid>eNrjZDB3yszPTSzKTi1SSMsvUkgsyS_ITFZISS3KTSzJLMksVkjMS1FILCjIyUwGCuTnKZRkpBal5qfxMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JJ4Zz9DQzMLc1Mzc1NHY2LUAADu_y5H</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Biomarker for atopic dermatitis and application thereof</title><source>esp@cenet</source><creator>LIU JUNFENG ; ZHANG KAI ; MO XIUMEI ; YE SIQI ; YAN FENGGEN ; YU XIAOBO ; CHEN DACAN ; WANG SAIYA</creator><creatorcontrib>LIU JUNFENG ; ZHANG KAI ; MO XIUMEI ; YE SIQI ; YAN FENGGEN ; YU XIAOBO ; CHEN DACAN ; WANG SAIYA</creatorcontrib><description>The invention discloses a biomarker for atopic dermatitis and application of the biomarker. The inventor of the invention adopts liquid chromatography-mass spectrometry and data independent acquisition technology detection to find that the expression of aminolevulinic acid dehydratase (ALAD) in the blood of an atopic dermatitis patient is obviously reduced, and the ALAD can be well used as a marker for atopic dermatitis diagnosis and reaction severity, can provide objective laboratory indexes for disease diagnosis, and has a good application prospect. Precise treatment can be realized, and the method has important significance for improving the clinical curative effect. 本发明公开了特应性皮炎的生物标志物及其应用。本发明的发明人采用液质联用、数据非依赖性采集技术检测,发现特应性皮炎患者血液中氨基乙酰丙酸脱水酶(ALAD)表达明显下降,其能够很好作为特应性皮炎诊断和反应严重程度的标志物,可以为疾病的诊断提供客观的实验室指标,有助于实现精准治疗,对于提高临床疗效有重要意义。</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PHYSICS ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231013&amp;DB=EPODOC&amp;CC=CN&amp;NR=116875675A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231013&amp;DB=EPODOC&amp;CC=CN&amp;NR=116875675A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LIU JUNFENG</creatorcontrib><creatorcontrib>ZHANG KAI</creatorcontrib><creatorcontrib>MO XIUMEI</creatorcontrib><creatorcontrib>YE SIQI</creatorcontrib><creatorcontrib>YAN FENGGEN</creatorcontrib><creatorcontrib>YU XIAOBO</creatorcontrib><creatorcontrib>CHEN DACAN</creatorcontrib><creatorcontrib>WANG SAIYA</creatorcontrib><title>Biomarker for atopic dermatitis and application thereof</title><description>The invention discloses a biomarker for atopic dermatitis and application of the biomarker. The inventor of the invention adopts liquid chromatography-mass spectrometry and data independent acquisition technology detection to find that the expression of aminolevulinic acid dehydratase (ALAD) in the blood of an atopic dermatitis patient is obviously reduced, and the ALAD can be well used as a marker for atopic dermatitis diagnosis and reaction severity, can provide objective laboratory indexes for disease diagnosis, and has a good application prospect. Precise treatment can be realized, and the method has important significance for improving the clinical curative effect. 本发明公开了特应性皮炎的生物标志物及其应用。本发明的发明人采用液质联用、数据非依赖性采集技术检测,发现特应性皮炎患者血液中氨基乙酰丙酸脱水酶(ALAD)表达明显下降,其能够很好作为特应性皮炎诊断和反应严重程度的标志物,可以为疾病的诊断提供客观的实验室指标,有助于实现精准治疗,对于提高临床疗效有重要意义。</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PHYSICS</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB3yszPTSzKTi1SSMsvUkgsyS_ITFZISS3KTSzJLMksVkjMS1FILCjIyUwGCuTnKZRkpBal5qfxMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JJ4Zz9DQzMLc1Mzc1NHY2LUAADu_y5H</recordid><startdate>20231013</startdate><enddate>20231013</enddate><creator>LIU JUNFENG</creator><creator>ZHANG KAI</creator><creator>MO XIUMEI</creator><creator>YE SIQI</creator><creator>YAN FENGGEN</creator><creator>YU XIAOBO</creator><creator>CHEN DACAN</creator><creator>WANG SAIYA</creator><scope>EVB</scope></search><sort><creationdate>20231013</creationdate><title>Biomarker for atopic dermatitis and application thereof</title><author>LIU JUNFENG ; ZHANG KAI ; MO XIUMEI ; YE SIQI ; YAN FENGGEN ; YU XIAOBO ; CHEN DACAN ; WANG SAIYA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116875675A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PHYSICS</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>LIU JUNFENG</creatorcontrib><creatorcontrib>ZHANG KAI</creatorcontrib><creatorcontrib>MO XIUMEI</creatorcontrib><creatorcontrib>YE SIQI</creatorcontrib><creatorcontrib>YAN FENGGEN</creatorcontrib><creatorcontrib>YU XIAOBO</creatorcontrib><creatorcontrib>CHEN DACAN</creatorcontrib><creatorcontrib>WANG SAIYA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LIU JUNFENG</au><au>ZHANG KAI</au><au>MO XIUMEI</au><au>YE SIQI</au><au>YAN FENGGEN</au><au>YU XIAOBO</au><au>CHEN DACAN</au><au>WANG SAIYA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Biomarker for atopic dermatitis and application thereof</title><date>2023-10-13</date><risdate>2023</risdate><abstract>The invention discloses a biomarker for atopic dermatitis and application of the biomarker. The inventor of the invention adopts liquid chromatography-mass spectrometry and data independent acquisition technology detection to find that the expression of aminolevulinic acid dehydratase (ALAD) in the blood of an atopic dermatitis patient is obviously reduced, and the ALAD can be well used as a marker for atopic dermatitis diagnosis and reaction severity, can provide objective laboratory indexes for disease diagnosis, and has a good application prospect. Precise treatment can be realized, and the method has important significance for improving the clinical curative effect. 本发明公开了特应性皮炎的生物标志物及其应用。本发明的发明人采用液质联用、数据非依赖性采集技术检测,发现特应性皮炎患者血液中氨基乙酰丙酸脱水酶(ALAD)表达明显下降,其能够很好作为特应性皮炎诊断和反应严重程度的标志物,可以为疾病的诊断提供客观的实验室指标,有助于实现精准治疗,对于提高临床疗效有重要意义。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN116875675A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PHYSICS
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
TESTING
VINEGAR
WINE
title Biomarker for atopic dermatitis and application thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T11%3A52%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LIU%20JUNFENG&rft.date=2023-10-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116875675A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true